AC
NVAX icon

AXQ Capital’s Novavax NVAX Stock Holding History

AXQ Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$645K Buy
68,480
+12,491
+22% +$112K 0.07% 403
2026
Q1 		$456K Buy
55,989
+26,022
+87% +$236K 0.06% 442
2025
Q4 		$201K Sell
29,967
-21,294
-42% -$161K 0.05% 570
2025
Q3 		$444K Buy
+51,261
New +$399K 0.17% 215
2025
Q2 		– Sell
-13,831
Closed -$88.7K – 714
2025
Q1 		$88.7K Buy
+13,831
New +$114K 0.04% 447
2023
Q3 		– Sell
-17,800
Closed -$132K – 560
2023
Q2 		$132K Buy
17,800
+3,814
+27% +$30K 0.16% 225
2023
Q1 		$96.9K Buy
+13,986
New +$129K 0.04% 446

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

AXQ Capital's NVAX Position: Q2 2026 in Review

AXQ Capital increased its Novavax (NVAX) stake by 22% in Q2 2026, buying an estimated $112K and bringing the position to 68,480 shares worth $645K. The position accounts for 0.07% of the portfolio, ranked #403.

AXQ Capital first reported a position in NVAX in Q1 2023 and has held it in 7 quarters since. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • AXQ Capital held 68,480 shares of Novavax worth $645K as of Q2 2026.
  • AXQ Capital bought 12,491 Novavax shares in Q2 2026, an estimated $112K.
  • Novavax made up 0.07% of AXQ Capital's portfolio in Q2 2026, its #403 holding.
  • AXQ Capital first reported a position in Novavax in Q1 2023 and has held it in 7 quarters since.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.